A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer

Abstract excerpt

Background: Individualized recurrence risk prediction in patients with stage II/III colorectal cancer (CRC) is crucial for making postoperative treatment decisions. However, there is still a lack of effective approaches for identifying patients with stage II and III CRC at a high risk of recurrence. In this study, we aimed to establish a credible gene model for improving the risk assessment of patients with stage...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colorectal Cancer Treatments and Studies
• Share to Ferroptosis and cancer prognosis
• Share to Genetic factors in colorectal cancer